Development of Co-Amorphous Systems for Inhalation Therapy—Part 1: From Model Prediction to Clinical Success

Development of Co-Amorphous Systems for Inhalation Therapy—Part 1: From Model Prediction to Clinical Success

<b>Background/Objectives</b>: The integration of machine learning (ML) and artificial intelligence (AI) has revolutionized the pharmaceutical industry by improving drug discovery, development and manufacturing processes. Based on literature data, an ML model was developed by our group to...

Full description

Saved in:
Bibliographic Details
Main Authors: Eleonore Fröhlich, Aurora Bordoni, Nila Mohsenzada, Stefan Mitsche, Hartmuth Schröttner, Sarah Zellnitz-Neugebauer
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Pharmaceutics
Subjects:
co-amorphous
machine learning
inhalation
tuberculosis
ethambutol
rifampicin
Online Access:https://www.mdpi.com/1999-4923/17/7/922
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items